PPARG and metabolic dysfunction-associated steatotic liver disease: According to our previous results, apigenin acts as a modulator of PPAR-γ and can ameliorate non-alcoholic fatty liver disease via the novel regulation of PPAR-γ and the inhibition of oxidative stress [50].